At close: December 23 at 5:35:02 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jean-Claude Maurel M.D., MHB | Chairman of the Management Board, CEO & President | -- | -- | -- |
| Mr. Mario Alcaraz | Member of the Executive Board & General Secretary | -- | -- | -- |
Medesis Pharma S.A.
LOrEe des Mas
BAt. Les CyprEs Avenue du Golf Baillargues
Montpellier, 34670
France
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 10
Description
Medesis Pharma S.A. operates as a biopharmaceutical company. The company's products include NanoLithium (NP03) for the treatment of Alzheimer's disease; NanosiRNA HD and NanoP42T to treat Huntington's disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France.
Corporate Governance
Medesis Pharma S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2024 at 10:59 AM UTC
Medesis Pharma S.A. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ALINT.PA IntegraGen SA
0.5300
0.00%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0790
+3.95%
ALDVI.PA Advicenne S.A.
1.9900
+8.03%
PHXM.PA PHAXIAM Therapeutics S.A.
1.7000
-1.28%
ALNEV.PA Neovacs S.A.
1.1500
+1.75%
ALCOX.PA Nicox S.A.
0.2900
-0.68%
ALCLS.PA Cellectis S.A.
1.5000
+0.54%
ALTME.PA TME Pharma N.V.
0.0746
-1.84%
OSE.PA OSE Immunotherapeutics SA
7.01
-0.71%
POXEL.PA Poxel S.A.
0.1300
+1.88%